JOHN SULLIVAN: Open Payments
NPI 1407056708 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 10 payments from 4 companies in 2025. Trend: 2023 $108 · 2024 $232 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $103 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $30 |
| Myriad Genetic Laboratories, Inc. | 2 | $29 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
Products named: GEMTESA, PYLARIFY, PROLARIS, ADSTILADRIN.
Industry payments across PA — which companies pay providers there.
